Molina Healthcare Stock Forecast, Price & News

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Molina Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MOH, but not buy additional shares or sell existing shares.
View analyst ratings for Molina Healthcare or view top-rated stocks.

14 Wall Street research analysts have issued 12 month target prices for Molina Healthcare's stock. Their MOH stock forecasts range from $300.00 to $390.00. On average, they anticipate Molina Healthcare's stock price to reach $341.00 in the next twelve months. This suggests a possible upside of 27.7% from the stock's current price.
View analysts' price targets for Molina Healthcare or view top-rated stocks among Wall Street analysts.

Molina Healthcare's stock was trading at $318.08 on January 1st, 2022. Since then, MOH stock has decreased by 16.0% and is now trading at $267.13.
View the best growth stocks for 2022 here.

Molina Healthcare is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for Molina Healthcare.

Molina Healthcare will be holding an earnings conference call on Thursday, July 28th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 877-344-7529 with passcode "9675380".

Molina Healthcare, Inc. (NYSE:MOH) released its quarterly earnings results on Wednesday, April, 27th. The company reported $4.90 earnings per share for the quarter, beating analysts' consensus estimates of $4.74 by $0.16. The company had revenue of $7.77 billion for the quarter, compared to the consensus estimate of $7.54 billion. Molina Healthcare had a trailing twelve-month return on equity of 31.85% and a net margin of 2.37%. During the same period in the prior year, the company earned $4.44 EPS.
View Molina Healthcare's earnings history.

170 employees have rated Molina Healthcare CEO Joseph Zubretsky on Glassdoor.com. Joseph Zubretsky has an approval rating of 82% among Molina Healthcare's employees.

Some companies that are related to Molina Healthcare include UnitedHealth Group (UNH), Anthem (ANTM), Cigna (CI), Humana (HUM) and Centene (CNC).
View all of MOH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Molina Healthcare investors own include NVIDIA (NVDA), Alibaba Group (BABA), PayPal (PYPL), Bank of America (BAC), Johnson & Johnson (JNJ), Netflix (NFLX), Tesla (TSLA), UnitedHealth Group (UNH), CVS Health (CVS) and Intel (INTC).

Molina Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "MOH."

Molina Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.99%), Capital World Investors (9.20%), BlackRock Inc. (7.10%), Wellington Management Group LLP (4.35%), State Street Corp (4.19%) and Renaissance Technologies LLC (3.09%). Company insiders that own Molina Healthcare stock include Dale B Wolf, Daniel Cooperman, Garrey Carruthers, Jeff D Barlow, Ronna Romney, Steven J Orlando and Thomas L Tran.
View institutional ownership trends for Molina Healthcare.

MOH stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Wellington Management Group LLP, American Century Companies Inc., Principal Financial Group Inc., Renaissance Technologies LLC, Bank of New York Mellon Corp, American International Group Inc., and Polar Capital Holdings Plc. Company insiders that have sold Molina Healthcare company stock in the last two years include Dale B Wolf, Daniel Cooperman, Garrey Carruthers, Jeff D Barlow, Ronna Romney, Steven J Orlando, and Thomas L Tran.
View insider buying and selling activity for Molina Healthcare or view top insider-selling stocks.

MOH stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Durable Capital Partners LP, Invesco Ltd., State Street Corp, Goldman Sachs Group Inc., Lord Abbett & CO. LLC, Eagle Asset Management Inc., and APG Asset Management N.V..
View insider buying and selling activity for Molina Healthcare or or view top insider-buying stocks.

Shares of MOH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MOH stock can currently be purchased for approximately $267.13.

Molina Healthcare (NYSE:MOH) has a market capitalization of $15.68 billion and generates $27.77 billion in revenue each year. The company earns $659 million in net income (profit) each year or $11.75 on an earnings per share basis.

Molina Healthcare employs 14,000 workers across the globe.

Molina Healthcare was founded in 1980.

Molina Healthcare's mailing address is 200 OCEANGATE SUITE 100, LONG BEACH CA, 90802. The official website for Molina Healthcare is www.molinahealthcare.com. The company can be reached via phone at (562) 435-3666, via email at [email protected], or via fax at 562-499-0790.